Statement: the primary trial participants recieve less than 300mg/m^2 doses of Pralatrexate. human chorionic gonadotropin measurement is a laboratory test to detect the amount of human chorionic gonadotropin in a biospecimen.
Primary_evidence: INTERVENTION 1:    Pralatrexate   Study drug 190 mg/m^2 for 2 to 4 weeks.